| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Revenue | 138 | 144 | 144 | 127 | 168 | 161 | 192 | 221 | 242 | 218 | 277 | 317 |
| Expenses | 129 | 132 | 138 | 138 | 158 | 150 | 169 | 193 | 203 | 186 | 218 | 228 |
| EBITDA | 9 | 13 | 6 | -11 | 11 | 11 | 24 | 29 | 40 | 32 | 59 | 89 |
| Operating Profit % | 6 % | 8 % | 4 % | -9 % | 6 % | 5 % | 10 % | 12 % | 14 % | 11 % | 19 % | 19 % |
| Depreciation | 3 | 3 | 2 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 |
| Interest | 5 | 5 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 2 | 4 | 14 | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 79 |
| Tax | 1 | 1 | 3 | -0 | 2 | 2 | 5 | 8 | 8 | 7 | 15 | 16 |
| Net Profit | 1 | 3 | 12 | -12 | 7 | 8 | 17 | 19 | 27 | 23 | 55 | 62 |
| EPS in ₹ | 0.45 | 1.24 | 4.53 | -4.41 | 2.75 | 3.00 | 6.51 | 7.20 | 10.20 | 8.49 | 8.26 | 9.20 |











Bandhan BSE Healthcare Index Fund Direct-Growth
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
